| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
HDAC8 |
IPI00020544 |
0.347 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
PTPRR |
PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor |
0.347 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
DSP |
DSP: Desmoplakin |
0.347 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
0.347 |
Evidence |
|
| IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
0.347 |
Evidence |
|
| ELA3B |
ELA3B: Elastase-3B precursor |
CDC42 |
IPI00016786 |
0.347 |
Evidence |
|
| CCK |
CCK: Cholecystokinins precursor |
PCSK9 |
PCSK9, NARC1, PSEC0052: Proprotein convertase subtilisin/kexin type 9 precursor |
0.347 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
0.347 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
0.347 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
LOC642558 |
FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 |
0.347 |
Evidence |
|
| KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
GRK6 |
IPI00220242 |
0.347 |
Evidence |
|
| KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
MAP2K3 |
IPI00218858 |
0.347 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
PSCD2 |
IPI00015228 |
0.347 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SLC37A4 |
G6PC, G6PT: Glucose-6-phosphatase |
0.347 |
Evidence |
|
| APCS |
APCS, PTX2: Serum amyloid P-component precursor |
ENPP7 |
ENPP7, UNQ3077/PRO9912: Ectonucleotide pyrophosphatase/phosphodiesterase family |
0.347 |
Evidence |
|
| APCS |
APCS, PTX2: Serum amyloid P-component precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
0.347 |
Evidence |
|
| LMNA |
LMNA, LMN1: Lamin-A/C |
DSG2 |
DSG2: Desmoglein-2 precursor |
0.347 |
Evidence |
|
| CST3 |
CST3: Cystatin-C precursor |
CTSE |
CTSE: Cathepsin E precursor |
0.347 |
Evidence |
|
| HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
TFEC |
TFEC, Tfec, tcag7.74: TFEC isoform |
0.347 |
Evidence |
|
| SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.347 |
Evidence |
|
| SCN7A |
SCN7A, SCN6A: Sodium channel protein type 7 subunit alpha |
SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
0.347 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
RIN3 |
IPI00329749 |
0.347 |
Evidence |
|
| HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
MICA |
MICA: MHC class I chain-related protein A |
0.347 |
Evidence |
|
| TLR6 |
TLR6: Toll-like receptor 6 precursor |
TLR5 |
IPI00656104 |
0.347 |
Evidence |
|
| TRPC6 |
TRPC6, TRP6: Short transient receptor potential channel 6 |
SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
0.347 |
Evidence |
|